Notice of Lodging of First Amendment To Consent Decree Under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (“CERCLA”), 64671-64672 [07-5693]

Download as PDF Federal Register / Vol. 72, No. 221 / Friday, November 16, 2007 / Notices U.S. Treasury or, if by e-mail or fax, forward a check in that amount to the Consent Decree Library at the stated address. Henry Friedman, Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 07–5696 Filed 11–15–07; 8:45 am] BILLING CODE 4410–15–M DEPARTMENT OF JUSTICE mstockstill on PROD1PC66 with NOTICES Notice of Lodging of Consent Decree Under the Comprehensive Environmental Response, Compensation and Liability Act Notice is hereby given that on October 31, 2007, a proposed Consent Decree in United States of America v. The Kansas City Southern Ry. Co., Civil Action No. 1:07–CV–1793, was lodged with the United States District Court for the Western District of Louisiana. In this action the United States sought injunctive relief and recovery of costs under Comprehensive Environmental Response, Compensation, and Liability Act (‘‘CERCLA’’) sections 106(a) and 107, 42 U.S.C. 9606(a) and 9607, in connection with the release or threatened release of hazardous substances into the environment at the Ruston Foundry Superfund Site located at 1010 Bogan Street in Alexandria, Rapids Parish, Louisiana (‘‘the Site’’). The Consent Decree resolves the United States’ claims in connection with the Site against The Kansas City Southern Railway Co. (‘‘KCSR’’) under CERCLA sections 106 and 107, 42 U.S.C. 9606 & 9607. Under the proposed Consent Decree, KCSR will (1) perform the remedy selected by the United States Environmental Protection Agency for the Site; (2) pay $750,000 to the United States for response costs incurred through October 30, 2006; and (3) pay all response costs incurred by the United States after October 30, 2006. The Department of Justice will receive for a period of thirty (30) days from the date of this publication comments relating to the Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and either e-mailed to pubcomment-ees.enrd@usdoj.gov or mailed to P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611, and should refer to United States of America v. The Kansas City Southern Ry. Co., D.J. Ref. 90–11–2– 08002. The Consent Decree may be examined at the Office of the United States VerDate Aug<31>2005 21:48 Nov 15, 2007 Jkt 214001 Attorney, Western District of Louisiana, 800 Lafayette Street, Suite 2200, Lafayette, LA 70501, and at U.S. EPA Region 6, 1445 Ross Avenue, Dallas, TX 75202. During the public comment period, the Consent Decree, may also be examined on the following Department of Justice Web site: http:// www.usdoj.gov/enrd/ Consent_Decrees.html. A copy of the Consent Decree may also be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $71.75 (25 cents per page reproduction cost) for a complete copy of the Consent Decree with all exhibits or $14.25 (25 cents per page reproduction cost) for a copy of the Consent Decree exclusive of exhibits. If the request is made by e-mail or fax, please forward a check in the appropriate amount to the Consent Decree Library at the stated address. The check should be payable to the U.S. Treasury. Thomas A. Mariani, Jr., Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 07–5695 Filed 11–15–07; 8:45 am] BILLING CODE 4410–15–M DEPARTMENT OF JUSTICE Notice of Lodging Proposed Consent Decree In accordance with Department Policy, 28 CFR 50.7, notice is hereby given that a proposed Consent Decree in United States v. Kenneth L. Mims and Leonard R. Cannon AKA Robby Cannon, Civil No. 2:07–cv–03624–PMD, was lodged with the United States District Court for the District of South Carolina on November 8, 2007. This proposed Consent Decree concerns a complaint filed by the United States against Kenneth L. Mims and Leonard R. Cannon AKA Robby Cannon, pursuant to section 301(a) of the Clean Water Act, 33 U.S.C. 1311(a), to obtain injunctive relief and impose civil penalties against the Defendants for violating the Clean Water Act by discharging fill material without a permit into waters of the United States. The proposed Consent Decree resolves these allegations by requiring the Defendants to pay a civil penalty. In addition, Defendants have agreed to a PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 64671 restoration plan which includes removing the sediment material deposited by the unpermitted dredging. The Department of Justice will accept written comments relating to this proposed Consent Decree for thirty (30) days from the date of publication of this Notice. Please address comments to Emery Clark, Assistant United States Attorney, United States Attorney’s Office, Wachovia Building, Suite 500, 1441 Main Street, Columbia, South Carolina 29201, and refer to United States v. Kenneth L. Mims and Leonard R. Cannon AKA Robby Cannon, United States District Court for the District of South Carolina, Civil No. 2:07–cv– 03624–PMD. The proposed Consent Decree may be examined at the Clerk’s Office, United States District Court for the District of South Carolina, 901 Richland Lane, Columbia, South Carolina. In addition, the proposed Consent Decree may be viewed at http://www.usdoj.gov/enrd/ Consent_Decrees.html. Stephen Samuels, Assistant Chief, Environmental Defense Section, Environment & Natural Resources Division. [FR Doc. 07–5690 Filed 11–15–07; 8:45 am] BILLING CODE 4410–15–M DEPARTMENT OF JUSTICE Notice of Lodging of First Amendment To Consent Decree Under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (‘‘CERCLA’’) Notice is hereby given that on October 30, 2007, a proposed First Amendment to Consent Decree in United States v. Stauffer Management Company LLC and Bayer CropScience Inc., Civil Action No. 8:05–cv–1024, was lodged with the United States District Court for the Middle District of Florida. The proposed First Amendment to Consent Decree implements a modification to the CERCLA remedial action at the Stauffer Chemical Superfund Site in Tarpon Springs, Pinellas County, Florida (the ‘‘Site’’) adopted by the U.S. Environmental Protection Agency through an Explanation of Significant Differences to the July 1998 Record of Decision with respect to Operable Unit 1 (Soils) at the Site. The remedy originally selected by EPA called for in-situ stabilization of contaminated sediments in wastewater ponds at the Site, using a cement slurry wall. During testing for the slurry wall, a reaction occurred between residual elemental phosphorus in the ponds and the slurry wall cement, resulting in a E:\FR\FM\16NON1.SGM 16NON1 64672 Federal Register / Vol. 72, No. 221 / Friday, November 16, 2007 / Notices fire in the test area. In response, EPA determined that a cut off wall should be substituted for the in-situ stabilization approach to the wastewater ponds. The Amendment modifies the original Consent Decree to ensure that this remedy modification is enforceable. The Department of Justice will receive for a period of thirty (30) days from the date of this publication comments relating to the First Amendment to Consent Decree. Comments should be addressed to the Assistant Attorney General, Environmental and Natural Resources Division, and either e-mailed to pubcomment-ees.enrd@usdoj.gov or mailed to P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611, and should refer to United States v. Stauffer Management Company LLC and Bayer CropScience Inc., D.J. Ref. 90–11–2–1227/3. The First Amendment to Consent Decree may be examined at the Office of the United States Attorney, 400 North Tampa Street, Suite 3200, Tampa, Florida 33602, and at U.S. EPA Region 4, 61 Forsyth Street, Atlanta, Georgia 30303–8960. During the public comment period, the First Amendment to Consent Decree, may also be examined on the following Department of Justice Web Site, to http:// www.usdoj.gov/enrd/ Consent_Decrees.html. A copy of the First Amendment to Consent Decree may also be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or emailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $3.50 (25 cents per page reproduction cost) payable to the U.S. Treasury or, if by e-mail or fax, forward a check in that amount to the Consent Decree Library at the stated address. Henry Friedman, Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 07–5693 Filed 11–15–07; 8:45 am] BILLING CODE 4410–15–M DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated July 31, 2007 and published in the Federal Register on August 9, 2007, (72 FR 44859), Almac Clinical Services Inc., (ACSI), 2661 Audubon Road, Audubon, Pennsylvania 19403, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II: Drug Schedule Oxycodone (9143) ........................ Fentanyl (9801) ............................ II II The company plans to import small quantities of the listed controlled substances in dosage form to conduct clinical trials. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Almac Clinical Services Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Almac Clinical Services Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: November 6, 2007. Joseph T. Rannazzisi, Deputy Assistant, Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–22512 Filed 11–15–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated July 10, 2007, and published in the Federal Register on July 24, 2007, (72 FR 40331), American Radiolabeled Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: mstockstill on PROD1PC66 with NOTICES Drug Schedule Gamma hydroxybutyric acid (2010) ............................................................................................................................................................ Ibogaine (7260) ........................................................................................................................................................................................... Lysergic acid diethylamide (7315) ............................................................................................................................................................... Tetrahydrocannabinols (7370) ..................................................................................................................................................................... Dimethyltryptamine (7435) .......................................................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... Dihydromorphine (9145) .............................................................................................................................................................................. Normorphine (9313) .................................................................................................................................................................................... Amphetamine (1100) ................................................................................................................................................................................... Methamphetamine (1105) ........................................................................................................................................................................... Amobarbital (2125) ...................................................................................................................................................................................... Phencyclidine (7471) ................................................................................................................................................................................... Phenylacetone (8501) ................................................................................................................................................................................. Cocaine (9041) ............................................................................................................................................................................................ Codeine (9050) ............................................................................................................................................................................................ Dihydrocodeine (9120) ................................................................................................................................................................................ Oxycodone (9143) ....................................................................................................................................................................................... Hydromorphone (9150) ............................................................................................................................................................................... Ecgonine (9180) .......................................................................................................................................................................................... Hydrocodone (9193) .................................................................................................................................................................................... Meperidine (9230) ....................................................................................................................................................................................... Metazocine (9240) ....................................................................................................................................................................................... VerDate Aug<31>2005 21:48 Nov 15, 2007 Jkt 214001 PO 00000 Frm 00099 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1 I I I I I I I I II II II II II II II II II II II II II II

Agencies

[Federal Register Volume 72, Number 221 (Friday, November 16, 2007)]
[Notices]
[Pages 64671-64672]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-5693]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE


Notice of Lodging of First Amendment To Consent Decree Under the 
Comprehensive Environmental Response, Compensation, and Liability Act 
of 1980 (``CERCLA'')

    Notice is hereby given that on October 30, 2007, a proposed First 
Amendment to Consent Decree in United States v. Stauffer Management 
Company LLC and Bayer CropScience Inc., Civil Action No. 8:05-cv-1024, 
was lodged with the United States District Court for the Middle 
District of Florida.
    The proposed First Amendment to Consent Decree implements a 
modification to the CERCLA remedial action at the Stauffer Chemical 
Superfund Site in Tarpon Springs, Pinellas County, Florida (the 
``Site'') adopted by the U.S. Environmental Protection Agency through 
an Explanation of Significant Differences to the July 1998 Record of 
Decision with respect to Operable Unit 1 (Soils) at the Site. The 
remedy originally selected by EPA called for in-situ stabilization of 
contaminated sediments in wastewater ponds at the Site, using a cement 
slurry wall. During testing for the slurry wall, a reaction occurred 
between residual elemental phosphorus in the ponds and the slurry wall 
cement, resulting in a

[[Page 64672]]

fire in the test area. In response, EPA determined that a cut off wall 
should be substituted for the in-situ stabilization approach to the 
wastewater ponds. The Amendment modifies the original Consent Decree to 
ensure that this remedy modification is enforceable.
    The Department of Justice will receive for a period of thirty (30) 
days from the date of this publication comments relating to the First 
Amendment to Consent Decree. Comments should be addressed to the 
Assistant Attorney General, Environmental and Natural Resources 
Division, and either e-mailed to pubcomment-ees.enrd@usdoj.gov or 
mailed to P.O. Box 7611, U.S. Department of Justice, Washington, DC 
20044-7611, and should refer to United States v. Stauffer Management 
Company LLC and Bayer CropScience Inc., D.J. Ref. 90-11-2-1227/3.
    The First Amendment to Consent Decree may be examined at the Office 
of the United States Attorney, 400 North Tampa Street, Suite 3200, 
Tampa, Florida 33602, and at U.S. EPA Region 4, 61 Forsyth Street, 
Atlanta, Georgia 30303-8960. During the public comment period, the 
First Amendment to Consent Decree, may also be examined on the 
following Department of Justice Web Site, to http://www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the First Amendment to Consent Decree 
may also be obtained by mail from the Consent Decree Library, P.O. Box 
7611, U.S. Department of Justice, Washington, DC 20044-7611 or by 
faxing or e-mailing a request to Tonia Fleetwood 
(tonia.fleetwood@usdoj.gov), fax no. (202) 514-0097, phone confirmation 
number (202) 514-1547. In requesting a copy from the Consent Decree 
Library, please enclose a check in the amount of $3.50 (25 cents per 
page reproduction cost) payable to the U.S. Treasury or, if by e-mail 
or fax, forward a check in that amount to the Consent Decree Library at 
the stated address.

Henry Friedman,
Assistant Chief, Environmental Enforcement Section, Environment and 
Natural Resources Division.
[FR Doc. 07-5693 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-15-M